🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsRetatrutide and fatty liver — MASH resolution rates in Phase 2 Page 5

Retatrutide and fatty liver — MASH resolution rates in Phase 2

MASHdoc_SA Mon, May 11, 2026 at 6:13 PM 23 replies 534 viewsPage 5 of 5
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
May 22, 2026 at 2:25 AM#21
jason_paloalto said:
One habit that pays for itself: post the method alongside the number.

Thank you for spelling out the reasoning rather than just the conclusion.

21 19robert_kc, dan_philly, MeganSA_TX and 18 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
May 26, 2026 at 12:19 AM#22

Adding the clinical framing, because it changes how the question reads. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

22 20InsuranceTom, WendyG_ATL, SaraMom3 and 19 others
Reply Quote Save Share Report
CryptoCarl
Member
789
3,456
May 2024
Arizona
May 29, 2026 at 10:10 PM#23
Dr.PathRoch said:
It helps to ask what evidence would change your mind before you look at any.

Same experience, arrived at from the opposite direction. I had assumed I was the exception until I read this.

23 21AussieAnna, BethLabQueen, ChrisMacros and 20 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Jun 2, 2026 at 8:00 PM#24
Dr.PathRoch said:
It helps to ask what evidence would change your mind before you look at any.

Adding the part of the answer the thread has not reached. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Last edited: Jun 2, 2026 at 9:00 PM
24 22Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 21 others
Reply Quote Save Share Report
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Jun 6, 2026 at 5:47 PM#25

One concrete data point for the thread. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

25 23BrianDallas92, labquiet_amy, emily_PDX and 22 others
Reply Quote Save Share Report
1345

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register